Kolbeck Roland Wilhelm's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Aug 4, 2026
- Accession no.
- 0002076327-26-000006
- Filed
- Aug 4, 2026, 5:03 PM ET
- Trade date
- Aug 1, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kolbeck Roland WilhelmCIK 0002076327 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | Common Stock | MOption exerciseAcquired | +36,375 | – | – | 36,375 | Direct | |
| Aug 1, 2026 | Common Stock | FTax withholdingDisposed | −12,385 | $5.20 | −$64,402 | 23,990 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | Common Stock | MOption exerciseDisposed | −36,375 | $0.00 | $0 | 109,125 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.